Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.13
+0.19 (3.85%)
At close: Mar 9, 2026, 4:00 PM EDT
5.18
+0.05 (0.97%)
After-hours: Mar 9, 2026, 5:48 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $375.76 million as of March 9, 2026. Its market cap has decreased by -27.55% in one year.
Market Cap
375.76M
Enterprise Value
296.00M
1-Year Change
-27.55%
Ranking
Category
Stock Price
$5.13
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $375.76M, an increase of 68.96%. That is a compound annual growth rate of 12.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 361.84M | 16.66% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monopar Therapeutics | 384.98M |
| Shattuck Labs | 379.05M |
| Ginkgo Bioworks Holdings | 378.35M |
| Aclaris Therapeutics | 369.02M |
| LENZ Therapeutics | 365.15M |
| Bicycle Therapeutics | 360.71M |
| Absci | 357.88M |
| Aura Biosciences | 355.62M |